Pahayahay, Rolando D.

HRN: 20-37-33  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/05/2023
CEFTRIAXONE 1G (VIAL)
07/05/2023
07/19/2023
IV
1gm
Q12
Complicated UTI
Waiting Final Action 
07/05/2023
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/05/2023
07/12/2023
IV
500 Mg
Q8h
Bowel Obstruction
Waiting Final Action 
07/05/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/05/2023
07/19/2023
IV
500 Mg
Q8h
Bowel Obstruction
Waiting Final Action 
07/20/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/20/2023
08/03/2023
IV
4.5 G
Q8h
T/C Sepsis
Waiting Final Action 
07/20/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/20/2023
07/27/2023
IV
500 Mg
Q8h
Neuroendocrine CA, Tumor Necrosis With Abdominal Involvement
Waiting Final Action 
07/29/2023
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
07/29/2023
08/05/2023
IV
4.5 G
Q8h
To Continue For 7 More Days
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: